Day: May 4, 2026

us corporate news

The Marzetti Company Reports Q3 2026 Earnings and Sales Results – Financial Highlights and Segment Performance

Minichart

May 4, 2026

The Marzetti Company Reports Q3 2026 Results: Growth, Challe...

Continue Reading 0

us corporate news

Digital Realty Trust, Inc. Announces ATM Equity Offering Sales Agreement with Leading Financial Institutions 13

Minichart

May 4, 2026

Digital Realty Trust, Inc. Files Form 8-K: Key Details for I...

Continue Reading 0

us corporate news

ADC Therapeutics SA Reports Q1 2026 Financial Results and Updates – NYSE: ADCT

Minichart

May 4, 2026

ADC Therapeutics Q1 2026 Financial Report: Detailed Investor...

Continue Reading 0

us corporate news

Ecovyst Inc. Share Purchase Agreement With INEOS Enterprises – Key Terms, Parties, and Definitions Explained

Minichart

May 4, 2026

Ecovyst Inc. Announces \$190 Million Acquisition of INEOS Ca...

Continue Reading 0

us corporate news

Rallybio Corporation Files Form 8-K with SEC Detailing Waiver Agreement and Entity Information

Minichart

May 4, 2026

Rallybio Corporation Terminates Merger Agreement with Candid...

Continue Reading 0

us corporate news

Strive, Inc. (NASDAQ: ASST) Files 8-K Announcing Merger with Semler Scientific and Details on Class A Common and Series A Preferred Stock

Minichart

May 4, 2026

Strive, Inc. 8-K Filing: Investor News Strive, Inc. An...

Continue Reading 0

us corporate news

Mirum Pharmaceuticals Reports Positive Volixibat Phase 3 Results for Cholestatic Pruritus in PSC – Efficacy and Safety Data Released

Minichart

May 4, 2026

Mirum Pharmaceuticals, Inc. 8-K Filing Detailed Report ...

Continue Reading 0

us corporate news

Strategy Inc Announces Update on Bitcoin Holdings and SEC Filing Details – May 2026

Minichart

May 4, 2026

Strategy Inc. 8-K Filing: ATM Update and Securities Overview...

Continue Reading 0

us corporate news

Jaguar Health, Inc. Files Form 8-K With SEC for May 2026 – Company Information, Nasdaq Listing, and Compliance Update

Minichart

May 4, 2026

Jaguar Health Receives Nasdaq Delisting Notice Due to Public...

Continue Reading 0

us corporate news

Kyverna Therapeutics Appoints Nadia Dac as Chief Commercial Officer to Lead Launch of miv-cel for Stiff Person Syndrome and Neuroimmunology Expansion

Minichart

May 4, 2026

Kyverna Therapeutics Appoints Nadia Dac as Chief Commercial ...

Continue Reading 0

Day: May 4, 2026

Join Our Investing Seminar